Nivolumab Can Increase Survival Rate in Head and Neck Cancer Patients
Advanced head and neck cancer that is resistant to chemotherapy is highly difficult to treat. However, an immunotherapy drug called
Read moreChemotherapy
Pancreatic Cancer: FAK Inhibitors to Chemotherapy and Immunotherapy might Increase Survival Rate
Pancreatic cancer is among the challenging cancers to treat; tumors of the pancreas usually do not react to present treatments.
Read moreNovel Method to Foresee Chemo-induced Heart Failure
A small number of patients treated with a common chemotherapy medicine, doxorubicin, develop serious heart damage, but there is presently
Read more